immatics biotechnologies GmbH
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $56,252 | $50,559 | $18,755 | $30,447 |
Gross Profit | 56,252 | 50,559 | 18,660 | -1,660 |
EBITDA | 46,579 | 915 | -14,524 | -10,528 |
EBIT | 43,503 | -2,118 | -17,626 | -13,560 |
Net Income | 44,863 | -8,570 | -18,022 | -3,071 |
Net Change In Cash | 56,252 | 50,559 | 18,755 | 30,447 |
Free Cash Flow | -60,210 | -36,530 | -35,989 | -42,026 |
Cash | 236,748 | 189,199 | 158,143 | 122,206 |
Basic Shares | 106,795 | 103,114 | 106,011 | 98,740 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $155,835 | $53,997 | $172,831 | $34,763 |
Gross Profit | 155,835 | -64,666 | 66,052 | -52,811 |
EBITDA | 34,457 | -88,929 | 50,041 | -83,560 |
EBIT | 22,232 | -96,163 | 43,199 | -89,029 |
Net Income | 15,218 | -96,994 | 37,514 | -95,061 |
Net Change In Cash | 155,835 | 53,997 | 172,831 | 34,763 |
Free Cash Flow | -174,510 | -12,729 | 93,916 | -87,441 |
Cash | 236,748 | 218,472 | 148,519 | 132,994 |
Basic Shares | 106,795 | 80,546 | 68,824 | 62,912 |
